Frederick M. Ausubel

Harvard University, Massachusetts General Hospital

Papers

4

Total Citations

381

H-Index

4

About

Frederick M. Ausubel is a pioneering molecular biologist whose research has fundamentally advanced our understanding of host-pathogen interactions and antimicrobial drug discovery. Working primarily at the intersection of infectious disease and model organism biology, Ausubel has championed the use of the nematode *Caenorhabditis elegans* as a powerful whole-animal platform for identifying novel therapeutics against dangerous pathogens. His development of high-throughput screening systems using *C. elegans* infected with clinically critical bacteria — including multidrug-resistant *Staphylococcus aureus* and *Enterococcus faecalis* — has opened transformative avenues for combating hospital-acquired infections, earning over 300 combined citations across his key antimicrobial studies. Beyond infectious disease, Ausubel has contributed to the history of genomic technology, documenting the evolution of first-generation automated DNA sequencing that helped make large-scale genomic projects feasible. His interdisciplinary approach extends even into computational biology, with work on probabilistic image analysis tools for resolving clustered worms in automated microscopy pipelines. Together, these contributions reflect a career defined by methodological innovation, bridging genetics, microbiology, and automation to address pressing biomedical challenges.

Research Focus

Key Achievements

4
H-Index
4
Papers
381
Total Citations
95
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Screen for Novel Antimicrobials using a Whole Animal Infection Model
210 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Harvard University, Massachusetts General Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago